Alcohol consumption, atherosclerotic progression, and prognosis among patients with coronary artery bypass grafts

Kenneth J Mukamal1, Saket Girotra, Murray A Mittleman

  • 1Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA. kmukamal@bidmc.harvard.edu

American Heart Journal
|January 31, 2006
PubMed

Insights

Moderate alcohol consumption showed a trend towards better outcomes and less graft progression in patients after coronary artery bypass surgery, though not statistically significant. Further research is needed to confirm these findings for coronary artery bypass graft patients.

Area of Science:

  • Cardiology
  • Public Health
  • Nutritional Science

Background:

  • Moderate alcohol consumption is linked to reduced mortality post-myocardial infarction.
  • The impact of alcohol intake on prognosis and graft obstruction in coronary artery bypass graft (CABG) patients remains unclear.

Purpose of the Study:

  • To investigate the association between alcohol consumption patterns and clinical outcomes in patients who have undergone coronary artery bypass graft surgery.
  • To assess the relationship between alcohol intake and the progression of coronary artery disease and graft obstruction.

Main Methods:

  • A cohort of 1351 patients from the Post-CABG trial, who had undergone bypass surgery, were analyzed.
  • Patients were categorized by weekly alcohol intake: abstention, light, moderate, and heavier drinking.
  • Clinical events and graft progression were assessed via coronary angiography and follow-up over a mean of 4.3 years.

Main Results:

  • A trend towards fewer clinical events (death, myocardial infarction, stroke, re-intervention) was observed in moderate drinkers (7-13 drinks/week).
  • Moderate alcohol intake also showed a trend towards less angiographic progression of coronary artery disease.
  • High-density lipoprotein cholesterol levels partially explained the observed trend toward lower risk in moderate drinkers.

Conclusions:

  • This study did not find statistically significant differences in prognosis based on alcohol intake in CABG patients.
  • However, inverse trends suggest potential benefits of moderate drinking on morbidity and graft progression, similar to other populations.
  • Larger studies are required to definitively establish the role of alcohol consumption in the long-term prognosis of patients with coronary artery bypass grafts.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...